For research use only. Not for therapeutic Use.
F 11440(Cat No.:I002333)is an experimental compound studied for its potential therapeutic applications, particularly in the field of oncology. It is a small molecule that acts as a selective inhibitor of specific signaling pathways involved in cancer cell growth, survival, and metastasis. F 11440 has shown promise in preclinical studies for its ability to target and disrupt key molecular targets, potentially enhancing the effectiveness of existing cancer treatments. Research is ongoing to assess its safety, pharmacokinetics, and efficacy in clinical trials, with the goal of developing it as a novel therapeutic option for cancer patients.
Catalog Number | I002333 |
CAS Number | 179756-58-2 |
Molecular Formula | C16H23N7O2 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | DMSO: ≤ 6 mg/mL (Need ultrasonic) |
Storage | -20°C |
IUPAC Name | 4-methyl-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2,4-triazine-3,5-dione |
InChI | InChI=1S/C16H23N7O2/c1-20-14(24)13-19-23(16(20)25)8-3-2-7-21-9-11-22(12-10-21)15-17-5-4-6-18-15/h4-6,13H,2-3,7-12H2,1H3 |
InChIKey | NMYAHEULKSYAPP-UHFFFAOYSA-N |
SMILES | CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=NC=CC=N3 |